Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | WDR5 | P61964 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.33 |
| ▸ | SALL4 | Q9UJQ4 | 1/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31566355 | 1.00 | ALDH1A1 (0.38) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL30391805 | 0.98 | ALDH1A1 (0.37) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL160594 | 0.98 | ALDH1A1 (0.37) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL16811762 | 0.89 | CYP1A2 (0.39) | ALDH1A1HSD17B10CYP2A6TSHRDNMT1 | |
| SCHEMBL9350829 | 0.89 | DNMT1 (0.39) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL7544297 | 0.88 | ALDH1A1 (0.35) | ALDH1A1HSD17B10DNMT1MAPTHIF1A | |
| SCHEMBL5608737 | 0.88 | DNMT1 (0.38) | ALDH1A1HSD17B10DNMT1MAPTHIF1A | |
| SCHEMBL4552955 | 0.86 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MAPTHIF1AMPI | |
| SCHEMBL17758852 | 0.86 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MAPTHIF1AMPI | |
| SCHEMBL1365289 | 0.86 | MAPT (0.58) | ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1650207-B1 | Process for producing optically active 3-quinuclidinols | TAKASAGO PERFUMERY CO LTD (JP) | 2007-06-27 | — | — | EP | claimed |
| EP-0466405-B1 | 2,2'-Bis(dicyclopenthylphosphino)-1-1'-binaphthyl and metal complexes thereof | TAKASAGO PERFUMERY CO LTD (JP) | 1995-02-22 | — | — | EP | claimed |
| US-5312939-A | 2,2'-bis (dicyclopentylphosphino)-1,1'-binaphthyl and transition metal complex using the same as ligand | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1994-05-17 | — | — | US | claimed |
| EP-0466405-A1 | 2,2'-Bis(dicyclopenthylphosphino)-1-1'-binaphthyl and metal complexes thereof | Takasago International Corporation (JP) | 1992-01-15 | — | — | EP | claimed |
| JP-4074192-A | — | — | None | — | — | JP | disclosed |
| US-20220169600-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | KYOWA PHARMA CHEMICAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| EP-3950672-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | Kyowa Pharma Chemical Co., Ltd. (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-10294193-B2 | Compound, and flavor composition and/or fragrance composition containing same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-05-21 | — | — | US | disclosed |
| EP-2966054-B1 | METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE | TAKASAGO PERFUMERY CO LTD (JP) | 2019-01-02 | — | — | EP | disclosed |
| US-10029969-B2 | Method of producing optically-active aldehyde | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| US-9896402-B2 | Method for preventing decrease in optical purity | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-02-20 | — | — | US | disclosed |
| US-9796678-B2 | Method for manufacturing optically active compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-24 | — | — | US | disclosed |
| EP-0466405-B1 | 2,2'-Bis(dicyclopenthylphosphino)-1-1'-binaphthyl and metal complexes thereof | TAKASAGO PERFUMERY CO LTD (JP) | 1995-02-22 | — | — | EP | disclosed |
| US-5312939-A | 2,2'-bis (dicyclopentylphosphino)-1,1'-binaphthyl and transition metal complex using the same as ligand | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1994-05-17 | — | — | US | disclosed |
| US-5312939-A | 2,2'-bis (dicyclopentylphosphino)-1,1'-binaphthyl and transition metal complex using the same as ligand | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1994-05-17 | — | — | US | disclosed |
| US-5306834-A | Catalytic hydrogenation of 4-methylene-2-oxetanone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1994-04-26 | — | — | US | disclosed |
| EP-0580336-A1 | Process for preparing optically active 4-methyl-2-oxetanone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1994-01-26 | — | — | EP | disclosed |
| JP-H0474192-A | 2,2'-BIS(DICYCLOPENTYLPHOSPHINO)-1,1'-BINAPHTHYL AND TRANSITION METAL COMPLEX COMPRISING THE SAME COMPOUND AS LIGAND | TAKASAGO INTERNATL CORP | 1992-03-09 | — | — | JP | disclosed |
| EP-0466405-A1 | 2,2'-Bis(dicyclopenthylphosphino)-1-1'-binaphthyl and metal complexes thereof | Takasago International Corporation (JP) | 1992-01-15 | — | — | EP | disclosed |
| EP-0466405-A1 | 2,2'-Bis(dicyclopenthylphosphino)-1-1'-binaphthyl and metal complexes thereof | Takasago International Corporation (JP) | 1992-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220169600-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | PTGS1, PTGER1, RACK1 | ALDH1A1 1425/4885HSD17B10 894/4885CYP2A6 275/4885 |
| US-10029969-B2 | Method of producing optically-active aldehyde | ALDH3A1, ALDH1A2, ADH1A | ALDH1A1 6/4885HSD17B10 41/4885CYP2A6 279/4885 |
| US-10294193-B2 | Compound, and flavor composition and/or fragrance composition containing same | FZD7, TAS1R1, TAS2R5 | ALDH1A1 83/4885HSD17B10 537/4885CYP2A6 2800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.